Search Tag: AI in medical imaging
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 02 Sep
Positron emission tomography (PET) is widely used in oncology and other areas of clinical practice for diagnosis, staging, treatment monitoring and follow-up. High-quality images are essential for detecting small lesions and guiding decisions, but image clarity is strongly linked to scan duration. While longer acquisitions improve image quality,...Read more
2025 17 Mar
Recent advancements in medical imaging have opened new possibilities for cancer diagnosis. Researchers at Empa have developed a novel 3D tissue analysis method for thyroid tumours using X-ray phase-contrast micro-computed tomography (micro-CT). This technology, enhanced by artificial intelligence, enables faster and more precise diagnoses without...Read more
2024 10 Nov
Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related mortality. Timely and accurate diagnosis is paramount for improving outcomes. Ultrasound is crucial as a supplementary imaging tool due to its wide availability, non-invasiveness and cost-effectiveness. However, operator dependency and...Read more
2024 10 Nov
Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related mortality. Timely and accurate diagnosis is paramount for improving outcomes. Ultrasound is crucial as a supplementary imaging tool due to its wide availability, non-invasiveness and cost-effectiveness. However, operator dependency and...Read more